| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |